Tandem Diabetes Care, Inc. (TNDM): Innovation and Market Position in Diabetes Management

Tandem Diabetes Care, Inc. (TNDM): Innovation and Market Position in Diabetes Management

ByMarketFacts

Tandem Diabetes Care, Inc. (TNDM) Tandem Diabetes Care, Inc., founded in 2006 and headquartered in San Diego, California, is a medical technology company specializing in insulin pump systems for people with diabetes. Their flagship product, the t:slim X2 Insulin Pump, integrates with continuous glucose monitoring (CGM) systems like Dexcom G6 and features advanced technologies such as Control-IQ and Basal-IQ for automated insulin delivery and predictive low-glucose suspension.

STAAR Surgical Company (NASDAQ: STAA): Enhancing Vision, Changing Lives

STAAR Surgical Company (NASDAQ: STAA): Enhancing Vision, Changing Lives

ByMarketFacts

STAAR Surgical Company (NASDAQ: STAA), headquartered in Monrovia, California, is a prominent medical device manufacturer focused on implantable lenses for the eyes, specifically targeting the correction of myopia and treatment of cataracts. Its flagship product, the Visian ICL (Implantable Collamer Lens), has gained significant traction as an alternative to traditional laser-based vision correction procedures like LASIK, offering patients a reversible option that avoids permanent alteration of the cornea

Hims & Hers Health, Inc. (NYSE: HIMS): Investing in the Future of Telehealth

Hims & Hers Health, Inc. (NYSE: HIMS): Investing in the Future of Telehealth

ByMarketFacts

Hims & Hers Health, Inc. (NYSE: HIMS) is a telehealth company that provides personalized health and wellness products and services, primarily focused on personal care, sexual health, mental health, and primary care. The company operates primarily through its digital platform, offering prescription and over-the-counter products, including hair loss, skincare, sexual wellness, and anxiety/depression treatments. 

Heal your portfolio with Apollo Medical Holdings, Inc. (NASDAQ:AMEH)

Heal your portfolio with Apollo Medical Holdings, Inc. (NASDAQ:AMEH)

ByMarketFacts

Apollo Medical Holdings Inc. (NASDAQ: AMEH) is a healthcare company that operates as an integrated population health management company. The company’s goal is to provide coordinated, value-based healthcare services to its patients, with a focus on the Medicare and Medicaid markets. The company operates in California and has contracts with various health plans, physician groups, and hospitals to provide its services.

The company provides a range of services, including primary care, specialty care, hospitalist services, and care coordination. It operates through its subsidiaries, including ApolloMed Hospitalists, Inc., ApolloMed ACO, Inc., and Network Medical Management, Inc.

How the diversified business model of Catalent, Inc (XNYS:CTLT) provides a safe investment opportunity?

How the diversified business model of Catalent, Inc (XNYS:CTLT) provides a safe investment opportunity?

ByMarketFacts

Catalent, Inc. (NYSE: CTLT) is a leading global provider of advanced delivery technologies, development, and manufacturing solutions for drugs, biologics, gene therapies, and consumer health products. Operating as a Contract Development and Manufacturing organization (CDMO), the company serves a wide range of customers in the pharmaceutical, biotech, and consumer health industries.
It operates under four main segments: biologics, softgel and oral technologies, oral and specialty delivery, and clinical supply services. The company is known for its expertise in developing and manufacturing complex and difficult-to-formulate products, and for its ability to rapidly scale up production to meet the needs of its customers.

Is it the right time to invest in this dividend growth stock :Medical Properties Trust, Inc. (XNYS:MPW)?

Is it the right time to invest in this dividend growth stock :Medical Properties Trust, Inc. (XNYS:MPW)?

ByMarketFacts

Medical Properties Trust Inc. (XNYS: MPW) is a REIT focused on healthcare facilities. One aspect of the company’s operations is the ownership and leasing of healthcare facilities. The United States generates the great majority of medical’s income, followed by Germany and the United Kingdom. Investment in mergers and acquisitions is a component of the company’s operational growth plan.

It offers to fund for a range of institutions requiring capital for acquisitions, sale-leasebacks, new developments, and expansion projects. Medical Properties Trust is committed to delivering strong financial results to its shareholders through a combination of steady cash flow, asset appreciation, and dividend growth

Can this cancer- curing company provide relief to your portfolio: Y-mAbs Therapeutics Inc. (NASDAQ: YMAB)?

Can this cancer- curing company provide relief to your portfolio: Y-mAbs Therapeutics Inc. (NASDAQ: YMAB)?

ByMarketFacts

Y-mAbs Therapeutics Inc. (XNAS: YMAB), incorporated in 2015 and headquartered in New York is a commercial-stage biopharmaceutical company focused on the development and commercialization of novel antibody-based therapeutic cancer products. In addition to conventional antibodies, the Company’s technologies include bispecific antibodies generated using the Y-BiClone platform and the SADA platform.

The Company’s broad and advanced product pipeline includes one FDA-approved product, DANYELZA, which targets tumors that express GD2, and one product candidate at the registration stage, OMBLASTYS, which targets tumors that express B7-H3.

Is Protagonist Therapeutics Inc. (NASDAQ: PTGX) a good buy from biotechnology Industry?

Is Protagonist Therapeutics Inc. (NASDAQ: PTGX) a good buy from biotechnology Industry?

ByMarketFacts

Protagonist Therapeutics, Inc.(XNAS:PGTX) is a biopharmaceutical company that discovers and develops peptide based therapeutic drugs to address hematology and blood disorders, as well as inflammatory and immunomodulatory diseases. It is developing rusfertide (PTG-300), an injectable hepcidin mimetic that is in Phase II clinical trials for the treatment of patients with polycythemia vera and hereditary hemochromatosis, as well as for the treatment of other blood disorders; PN-943, an oral, alpha-4-beta-7 antagonist peptide, which is currently in Phase II clinical trials for the treatment of inflammatory bowel disease (IBD); and PN-235, an interleukin-23 receptor antagonist for the treatment of both IBD and non-IBD indications. A license and collaboration agreement has been signed between the company and Janssen Biotech Inc.

Top 5 Healthcare Stocks Expected To Thrive Post Pandemic

Top 5 Healthcare Stocks Expected To Thrive Post Pandemic

ByMarketFacts

Healthcare has become one of the world’s largest sector, both in terms of revenue and employment. It comprises of hospitals, medical devices, equipment, insurance, medicines, and vaccines. The US healthcare industry is massive, with healthcare spending accounting for over 19.7% of US GDP in 2020. As a result, the healthcare sector in US is seeing strong and sustained growth.
Since the demand for healthcare products is ever increasing, the sector provides steady and consistent returns that are uncorrelated with the overall direction of the stock market. Here are the top 5 healthcare stocks to look out for.

Shall Investors punt on this pharmaceutical penny stock: Avenue Therapeutics Inc. (NASDAQ: ATXI)?

Shall Investors punt on this pharmaceutical penny stock: Avenue Therapeutics Inc. (NASDAQ: ATXI)?

ByMarketFacts

Avenue Therapeutics (XNAS: ATXI) is a specialty pharmaceutical company that develops and markets pharmaceutical products for the acute care setting. Its mission is to develop IV tramadol, a potential alternative that could reduce the use of conventional opioids, for patients suffering from acute pain in the U.S. Avenue is headquartered in New York City and was founded by Fortress Biotech, Inc. Fortress is focused on acquiring, developing and commercializing high-potential marketed and development-stage drugs and drug candidates.